AXT has signed an agreement to distribute stem cell solutions from StemBioSys to researchers in Australia and New Zealand.
Thermo Fisher Scientific has completed its acquisition of HighChem but terminated the agreement under which it would have acquired Gatan.
AMS Instrumentation & Calibration has been appointed the exclusive distributor for the Bronkhorst range of thermal, Coriolis and ultrasonic flowmeters and controllers for low flow rates of gases and liquids in Australia and its territories.
SCHOTT, an international technology group in the areas of specialty glass and glass ceramics, has entered into a purchase agreement to acquire Australian microfluidic company MINIFAB.
Scientific equipment supplier AXT has announced the formation of a new relationship with US-based Direct Electron — a producer of next-generation detection cameras for transmission electron microscopes (TEM).
Thermo Fisher Scientific has entered into a definitive agreement to acquire Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, for US$1.7 billion in cash.
AXT has signed an exclusive distribution agreement with ELEMISSION, a Canadian-based company that specialises in large-scale micro characterisation using continuous LIBS (laser-induced breakdown spectroscopy) scanning technology.
Arrow Pharmaceuticals and Apotex Australia have announced a proposed merger of their Australian and New Zealand generic pharmaceutical and OTC operations.
UNSW Vice-Chancellor Professor Ian Jacobs has signed agreements with France's largest government research organisation and the French Space Agency.
TissueGnostics is focused on integrated solutions for the scanning and analysis of microscopy slides, cytospins, smears and tissue microarrays.
Science & Technology Australia and the American Association for the Advancement of Science have pledged to foster collaborations to enhance the role of STEM on the global stage.
Zelda Therapeutics, an Australian-listed biotech focused on medical cannabis, has expanded its pancreatic cancer research collaboration agreement with Curtin University.
Merck has acquired Australian listed cancer research firm Viralytics in a $502 million deal.
Merck has entered into an agreement with Avanti Polar Lipids to be the exclusive multinational distributor of the latter's research lipids portfolio outside of the United States.
Particle & Surface Sciences (PsS) has been appointed distributor for Izon Science products across Australia.